Study Evaluating IMA-638 in Healthy Japanese
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00340327|
Recruitment Status : Completed
First Posted : June 21, 2006
Last Update Posted : December 5, 2007
|Condition or disease||Intervention/treatment||Phase|
|Healthy||Drug: IMA-638||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Intervention Model:||Single Group Assignment|
|Official Title:||An Ascending Single Dose Study of the Safety and Pharmacokinetics of IMA-638 Administered to Healthy Japanese Subjects|
|Study Start Date :||June 2006|
|Actual Study Completion Date :||July 2007|
- Safety will be measured by evaluating physical examinations, vital signs, electrocardiograms (ECGs), and clinical laboratory test results.
- Drug levels and associated biomarkers will be evaluated.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00340327
|United States, California|
|Glendale, California, United States, 91206|
|Study Director:||Medical Monitor||Wyeth is now a wholly owned subsidiary of Pfizer|